Ulrike Gnad-Vogt
Hoofd Techniek/Wetenschap/O&O bij CureVac SE
Actieve functies van Ulrike Gnad-Vogt
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Hoofd Techniek/Wetenschap/O&O | 01-01-2011 | - |
Loopbaan van Ulrike Gnad-Vogt
Eerdere bekende functies van Ulrike Gnad-Vogt
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CUREVAC N.V. | Hoofd Techniek/Wetenschap/O&O | 01-01-2011 | 01-01-2019 |
Corporate Officer/Principal | 01-01-2019 | - |
Opleiding van Ulrike Gnad-Vogt
Universität des Saarlandes | Doctorate Degree |
Statistieken
Internationaal
Duitsland | 4 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CUREVAC N.V. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Beurs
- Insiders
- Ulrike Gnad-Vogt
- Ervaring